Nonoperating Income (Expense) in USD of SELLAS Life Sciences Group, Inc. from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to Q3 2025.
  • SELLAS Life Sciences Group, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $292K, a 32.1% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $995K, a 102% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Nonoperating Income (Expense) for 2024 was $632K, a 19.5% increase from 2023.
  • SELLAS Life Sciences Group, Inc. annual Nonoperating Income (Expense) for 2023 was $529K, a 18.5% decline from 2022.
  • SELLAS Life Sciences Group, Inc. annual Nonoperating Income (Expense) for 2022 was $649K, a 85.1% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

SELLAS Life Sciences Group, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $995K $292K +$71K +32.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $924K $272K +$121K +80.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $803K $250K +$171K +216% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $632K $181K +$140K +341% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $492K $221K +$127K +135% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $365K $151K -$59K -28.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $424K $79K -$105K -57.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $529K $41K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $94K -$30K -24.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $210K +$1K +0.48% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $184K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $124K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $209K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q3 2019 -$4.2M -$3.91M -1349% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$3.13M +$2.77M +46.9% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q3 2018 -$290K +$4.1M +93.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$5.9M -$103K -1.78% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q3 2017 -$4.39M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$5.8M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q4 2014 $15.6M $44.3M +$57.8M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$42.2M -$6.17M +$1.96M +24.1% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-05
Q2 2014 -$44.2M -$19.9M -$11.9M -148% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 -$32.3M -$2.54M +$9.52M +79% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-06
Q4 2013 -$41.8M -$13.5M -$14.3M -1848% Oct 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
Q3 2013 -$27.5M -$8.13M -$7.4M -1009% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$20.1M -$8.06M -$14M -236% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$6.1M -$12.1M +$7.08M +37% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 -$13.2M $775K Oct 1, 2012 Dec 31, 2012 8-K 2015-12-04
Q3 2012 -$733K Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-07
Q2 2012 $5.91M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$19.1M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09

SELLAS Life Sciences Group, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $632K +$103K +19.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $529K -$120K -18.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $649K -$3.71M -85.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $4.36M +$4.15M +1995% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $208K +$19.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$19.4M +$9.68M +33.3% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-13
2018 -$29M -$5.55M -23.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$23.5M -$44.5M -212% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $21M +$25.4M Jan 1, 2016 Dec 31, 2016 10-K 2017-03-15
2015 -$4.37M -$20M -128% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 $15.6M +$57.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$41.8M -$28.6M -217% Jan 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
2012 -$13.2M -$22.3M -245% Jan 1, 2012 Dec 31, 2012 8-K 2015-12-04
2011 $9.08M +$4.45M +96% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $4.63M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.